20
Teva Pharmaceutical Industries Ltd Tel Aviv - Jaffa Il, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Trimethoprim, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2007-073 - Rev 01
This Chemical Type CEP, issued on December 21, 2021, remains in force until March 06, 2024, ensuring its reliability within the pharmaceutical industry.
Substance Number 60 associated with this CEP further emphasizes